Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 1-6 of 6 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2014Apoptosis, proliferation and inflammation are improved after treatment with the new selective glp-2 receptor agonist, elsiglutide, in a rat model of irinotecan-induced mucositisMayo, B.; Stringer, A.; Bateman, E.; Bowen, J.; Wignall, A.; Wozniak, B.; White, I.; Pietra, C.; Cantoreggi, S.; Keefe, D.; COSA's 41st Annual Scientific Meeting. Joining Forces - Accelerating Progress (2 Dec 2014 - 4 Dec 2014 : Melbourne, Vic.)
2011The effect of ErbB inhibition on chemotherapy-induced intestinal damageMayo, B.; Bowen, J.; Stringer, A.; Bateman, E.; Plews, E.; Darby, J.; Boyle, F.; Keefe, D.; International MASCC/ISOO Symposium (2011 : Athens, Greece)
2017Irinotecan-induced mucositis: the interactions and potential role of GLP-2 analoguesMayo, B.; Stringer, A.; Bowen, J.; Bateman, E.; Keefe, D.
2013Investigation of effect of nutritional drink on chemotherapy-induced mucosal injury and tumor growth in an established animal modelBateman, E.; Bowen, J.; Stringer, A.; Mayo, B.; Plews, E.; Wignall, A.; Greenberg, N.; Schiffrin, E.; Keefe, D.
2013Biomarkers of chemotherapy-induced diarrhoea: a clinical study of intestinal microbiome alterations, inflammation and circulating matrix metalloproteinasesStringer, A.; Al-Dasooqi, N.; Bowen, J.; Tan, T.; Radzuan, M.; Logan, R.; Mayo, B.; Keefe, D.; Gibson, R.
2011Pilot study of biomarkers of chemotherapy-induced Gastrointestinal ToxicityAl-Dasooqi, N.; Mayo, B.; Bowen, J.; Stringer, A.; Gibson, R.; Keefe, D.; Clinical Oncological Society of Australia Annual Scientific Meeting (38th : 2011 : Perth, Western Australia)